IIFL Finance Ltd. moves to reshape its capital structure

The EGM notice proposes the following preferential allotments:

The three investor allotments are identified in the EGM notice at ^[1], ^[1] and ^[2]; the promoter warrant allottees are defined at ^[3], with the warrant terms for the promoter entities set out at ^[2] and ^[4].

Pricing: The relevant date is 4 November 2026. The notice sets the SEBI ICDR floor price at ₹602 per security and the issue price at ₹602 per security. Therefore, the proposed issue is priced at the stated SEBI ICDR floor price, not at a premium to it ^[4].

Lock-in: The CCPS, the equity shares issued on conversion of the CCPS, the warrants and the equity shares issued on warrant conversion are to be locked in as prescribed under Regulation 167 of the SEBI ICDR Regulations ^{[5] [6] [7]}. The notice separately specifies a 90-trading-day lock-in from the allotment date for the promoters’ entire pre-preferential allotment shareholding ^[8]. Thus, 90 trading days is explicitly stated for the promoters’ existing holdings; the lock-in for the newly issued securities is stated by reference to the statutory Regulation 167 requirement rather than as one universal fixed period in the cited notice.

The authorized-share-capital increase is an enabling step, not the cash infusion itself. It creates sufficient legal share-capital headroom for IIFL Finance to issue the proposed CCPS and warrants; the immediate capital-adequacy benefit comes from the fully paid-up CCPS subscription.

• Capital-authority expansion: Authorized share capital is proposed to rise from ₹971.05 Cr to ₹5,621.05 Cr, an increase of ₹4,650.00 Cr. The equity-share authorization remains unchanged, while preference-share capacity rises to 8.5548 Cr shares of ₹602 face value, enabling the proposed CCPS issuance and subsequent conversions. ^[9] The filing states that the existing authorized capital was insufficient to accommodate the proposed securities and their conversion into equity. ^[10]
• Immediate capital support: The two investor groups are expected to provide approximately ₹5,150 Cr upfront—₹5,000 Cr from Ingot SG and ₹150 Cr from the Anchorage investors. The CCPS are fully paid on allotment, non-redeemable and intended to form permanent Tier 1 capital. ^{[11] [12]}
• Full potential issue size: Including the promoter warrants, the preferential issue totals ₹6,414.20 Cr, assuming all warrants are exercised. This comprises approximately ₹5,150 Cr of CCPS subscriptions and up to ₹1,264.20 Cr from promoter warrants. ^{[1] [11]}

Relative to current net worth

IIFL Finance’s latest reported standalone total equity—used here as the accounting proxy for net worth—was ₹8,597.9 Cr as at Q2 FY27. ^[13]

• Full ₹6,414.20 Cr issue: approximately 74.6% of current total equity, derived from ₹6,414.20 Cr ^[1] divided by ₹8,597.9 Cr ^[13].
• Immediate CCPS component of ₹5,150 Cr: approximately 59.9% of current total equity, derived from ₹5,150 Cr ^[11] divided by ₹8,597.9 Cr ^[13].

The capital need is material because, as at 30 September 2026, CRAR was 17.0% against a 15.0% minimum and Tier 1 capital ratio was 12.5% against a 12.0% minimum. On a fully implemented pro forma basis, the company expects CRAR to rise to 30.3%, Tier 1 capital ratio to 25.7%, and gearing to fall from 4.6x to 2.8x. ^[11] Thus, the authorized-capital amendment removes the issuance constraint, while the CCPS provide the immediate regulatory-capital buffer; the warrant component is incremental and contingent on exercise.

Net effect: Using the reported Fairfax reduction as the decline in the FIH Mauritius holding, the promoter-plus-major-shareholder block falls from approximately 38.4% before the preferential issue to 34.7% on the EGM notice’s post-issue, fully converted/exercised basis—a decline of roughly 3.7 percentage points.

• Fairfax-related sale: FIH Mauritius’ holding declined from 15.18% to 13.64%, reducing the combined block by 1.54 pp before the issue.
• Preferential issue effect: The notice shows promoter holding declining from 24.75% pre-issue to 23.74% post-issue, despite the promoters receiving warrants, because the denominator expands through the proposed securities. The post-issue table assumes full allotment and exercise/conversion of the relevant securities ^{[14] [14]}.
• Combined calculation: Promoters at 23.74% plus FIH/Fairfax at approximately 10.9% of the enlarged post-issue equity equals approximately 34.7%. This is 3.7 pp below the post-Fairfax-sale, pre-issue level of approximately 38.4%. Against the pre-sale combined level of approximately 39.9%, the reduction is about 5.3 pp.

Important timing distinction: Immediately after allotment but before CCPS conversion and warrant exercise, the voting dilution is deferred. The CCPS carry only the voting rights available to preference shareholders until conversion, while promoter warrants carry no voting rights until exercise ^{[12] [7]}. On that immediate post-allotment basis, the combined ordinary voting block remains approximately 38.4% after the Fairfax sale, implying only the 1.54 pp reduction attributable to Fairfax.

Board and control rights

The EGM notice does disclose governance changes, but not a transfer of management control:

• Venkataraman Rajamani is proposed to be re-designated from Joint Managing Director to Non-Executive Non-Independent Director ^[15].
• Investor 1 receives conditional rights to nominate two directors at roughly a 10% holding threshold, or one director at roughly 7.5%, subject to the specified conditions ^[16].
• The notice states that these rights do not dilute independent-director obligations and that the promoters and existing management will continue to lead the business ^[15].
• It also expressly states that there will be no change in control consequent to the preferential issue ^[17].

Therefore, the transaction changes the ownership mix and provides Investor 1 with minority board-representation and protective rights, but the notice does not disclose a change in management control or a transfer of majority control.